摘要:
The invention relates to an additive comprising at least 95 wt. % of a mixture consisting of at least one organic filter filtering UVA, at least one organic filter filtering UVB, and from 1 to 50 wt. % of at least one non-volatile oil that is a solvent for said filters. This composition is particularly useful as an agent for protecting the organoleptic properties of a transparent cosmetic composition, against UV radiation.
摘要:
The invention relates to an additive comprising at least 95 wt. % of a mixture consisting of at least one organic filter filtering UVA, at least one organic filter filtering UVB, and from 1 to 50 wt. % of at least one non-volatile oil that is a solvent for said filters. This composition is particularly useful as an agent for protecting the organoleptic properties of a transparent cosmetic composition, against UV radiation.
摘要:
The invention relates to a perfuming solution comprising a volatile alcohol, a perfume and a mixture for stabilizing said perfume consisting of at least one UV filter selected from the derivatives of cinnamate, at least one UV filter selected from the derivatives of dibenzoylmethane, and at least one non-volatile oil that is soluble in said alcohol and is a solvent for said filters, the stabilizing mixture being in sufficient amount to protect the perfuming solution from degradation by UV radiation.
摘要:
The subject of the invention is the use of an extract of Stevia in combination with a salt, for masking the bitterness of bitter compounds in cosmetic or dermatological compositions.This mixture of sweetener with a second gustatory agent makes it possible to mask the bitterness of the compound permanently without changing the nature of the fragrance or the colour of the composition.
摘要:
The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.
摘要翻译:所公开的物质恢复LOX和NRAGE蛋白之间的正常共表达和相互作用。 特别地,有效量的调节SEQ ID NO:1的LOX的表达和/或活性的物质和/或调节SEQ ID NO:2的NRAGE的表达和/或活性的物质可用于制造 用于调节LOX和NRAGE蛋白之间相互作用的组合物,以调节增殖,分化和凋亡的细胞现象之间的平衡,特别是在这些现象之间的平衡受到干扰的情况下,特别是在LOX和 NRAGE不存在或改变。 本发明可以特别地治疗和/或预防皮肤老化,扁平苔藓,移植物抗宿主反应(GVH),湿疹,牛皮癣和癌症,特别是上皮癌,特别是基底细胞或脊髓细胞的皮肤上皮癌 类型。
摘要:
The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation.
摘要:
The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation.
摘要:
The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.
摘要翻译:所公开的物质恢复LOX和NRAGE蛋白之间的正常共表达和相互作用。 特别地,有效量的调节SEQ ID NO:1的LOX的表达和/或活性的物质和/或调节SEQ ID NO:2的NRAGE的表达和/或活性的物质可用于制造 用于调节LOX和NRAGE蛋白之间相互作用的组合物,以调节增殖,分化和凋亡的细胞现象之间的平衡,特别是在这些现象之间的平衡受到干扰的情况下,特别是在LOX和 NRAGE不存在或改变。 本发明可以特别地治疗和/或预防皮肤老化,扁平苔藓,移植物抗宿主反应(GVH),湿疹,牛皮癣和癌症,特别是上皮癌,特别是基底细胞或脊髓细胞的皮肤上皮癌 类型。
摘要:
The invention relates to the use of a Rhodiola crenulata extract, via the topical route, for increasing the energy metabolism of the cutaneous tissues of a subject.The invention relates notably to topical compositions which comprise an active agent for increasing the energy metabolism of the cutaneous tissues of a subject, said active agent being a Rhodiola crenulata extract.The present invention enables making a cosmetic care such as: fighting against, or slowing down or preventing the loosening of the cutaneous tissue, increasing the plasticity of the cutaneous tissue, exerting an anti-wrinkle effect or slowing down or preventing the appearance of wrinkles, fighting against, slowing down or preventing the appearance of acne, exerting a depigmenting effect of the cutaneous tissue, in particular of the skin, and promoting desquamation of the cutaneous tissue (or “peeling”).
摘要:
This invention relates to the use of a preparation comprising sulfated oligosaccharides which trap spermine or spermidine or both, as an active slimming ingredient in a cosmetic, pharmaceutical and/or nutraceutical composition. One of the objectives of the invention is to supply a cosmetic, pharmaceutical or nutraceutical composition with a slimming effect.